This compound is an impurity standard for an active pharmaceutical ingredient, specifically a quinoline derivative with a fluorophenyl substituent. It is primarily used as a reference material in pharmaceutical manufacturing quality control.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 172336-32-2
Tert-Buthyl Pitavastatin
pharmaceutical raw material
Ethyl (E)-7-[4-(4'-fluorophenyl)-2-(cyclopropyl)-3-quinolinyl]-5-hydroxy-3-oxo-6-heptenoate
pharmaceutical raw material
(Z)-Pitavastatin calcium
pharmaceutical raw material
N'-(desmethyl)azithromycin
pharmaceutical raw material
Fosaprepitant
pharmaceutical raw material
7-Chloro-1-methyl-5-(4-oxocyclohexa-2,5-dien-1-ylidene)-1,3,4,5-tetrahydro-2H-1,4-benzodiazepin-2-one
pharmaceutical raw material
Butafosfan
pharmaceutical raw material
N-(4-Methylbenzene-1-sulfonyl)-N-(prop-2-en-1-yl)benzenecarbohydrazonic acid
pharmaceutical raw material
ethyl (E)-7-[2-cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl]-3,5-dihydroxyhept-6-enoate
MAUQAXOHCVNUMX-BUHFOSPRSA-N
CCOC(=O)CC(CC(/C=C/C1=C(C2=CC=CC=C2N=C1C3CC3)C4=CC=C(C=C4)F)O)O
—